LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-08-09
Case ID: NM_000268.3_c.863C_G_20260809_212822
Framework: ACMG/AMP 2015
Variant classification summary

NM_000268.3:c.863C>G

NF2  · NP_000259.1:p.(Ser288Ter)  · NM_000268.3
GRCh37: chr22:30061031 C>G  ·  GRCh38: chr22:29665042 C>G
Gene: NF2 Transcript: NM_000268.3
Final call
Likely Pathogenic
PVS1 very strong PM2 supporting
All criteria require review: For research and educational purposes only.
Gene
NF2
Transcript
NM_000268.3
Protein
NP_000259.1:p.(Ser288Ter)
gnomAD AF
ClinVar
Pathogenic
OncoKB
Likely Oncogenic
Interpretation summary
Generated evidence synthesis
1
PVS1 (Very Strong): Nonsense p.Ser288Ter truncates merlin at 288 of 595 amino acids and is predicted to trigger nonsense-mediated decay.
2
PM2 (Supporting): The variant is absent from gnomAD v2.1, v4.1, and gnomAD-Canada, three large population cohorts.
3
Together, PVS1 (very strong) plus PM2 (supporting) yields Likely Pathogenic under the ClinGen SVI 2020 combination rule (posterior probability 0.988).
Final determination: Generic ACMG/AMP 2015 fallback: PVS1 (very strong) + PM2 (supporting) = 1 very strong + 1 supporting, which is Likely Pathogenic under the ClinGen SVI 2020 PM2-downgrade addendum (PVS1 + 1 supporting criterion -> Likely Pathogenic, Post_P 0.988); the combination does not satisfy any Pathogenic rule (no 1 strong, no 2 moderate, and no 1 moderate + 1 supporting or 2 supporting alongside PVS1).
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Met Met (very strong): Nonsense change p.Ser288Ter truncates merlin at 288 of 595 amino acids and is predicted to trigger nonsense-mediated decay.
pvs1_generic_framework pvs1_gene_context pvs1_variant_assessment PMID:25741868 PMID:9643284 PMID:19545378 gnomad_v2 gnomad_v4 gnomad_canada spliceai
PS1 N/A Not applicable: as a nonsense change producing a stop codon, no altered amino acid exists to compare against a known pathogenic missense at this position.
generic_acmg_combination_rules
PS2 Not assessed Not assessed: no de novo occurrence report or parental genotype data were available for this variant.
generic_acmg_combination_rules clinvar
PS3 Not assessed Not assessed: no validated functional assay specific to this variant was available to demonstrate a damaging effect.
PMID:25741868 oncokb PMID:9643284 PMID:19545378 PMID:22825583 PMID:8755919 generic_acmg_combination_rules
PS4 Not met Not met: no case-control or cohort prevalence study exists; the only observation is a single laboratory submission, short of the multiple-unrelated-patients requirement.
clinvar PMID:25741868
PM1 N/A Not applicable: no altered residue exists to evaluate, as this is a nonsense change rather than a missense variant.
generic_acmg_combination_rules
PM2 Met Met (supporting): absent from gnomAD v2.1, v4.1, and gnomAD-Canada, three large population cohorts, in a gene with an established loss-of-function disease mechanism.
gnomad_v2 gnomad_v4 gnomad_canada
PM3 N/A Not applicable: this criterion applies only to recessive disorders, and NF2-related schwannomatosis is autosomal dominant.
PMID:25741868 PMID:19545378
PM4 N/A Not applicable: no protein length change occurs, so this criterion for in-frame insertions/deletions or stop-loss variants does not apply.
pvs1_generic_framework generic_acmg_combination_rules
PM5 N/A Not applicable: no missense change exists at this residue to compare against a previously pathogenic missense at the same position.
generic_acmg_combination_rules
PM6 Not assessed Not assessed: no unconfirmed de novo report or parental testing data were available for this variant.
generic_acmg_combination_rules clinvar
PP1 Not assessed Not assessed: no co-segregation data in affected family members were available for this variant.
generic_acmg_combination_rules clinvar
PP2 N/A Not applicable: no missense change is present, so the gene's missense-constraint properties are not relevant to this variant.
generic_acmg_combination_rules
PP3 N/A Not applicable: as a nonsense change, the truncating effect is established directly from the sequence; SpliceAI max delta 0.00 shows no competing splice effect.
spliceai bayesdel generic_acmg_combination_rules
PP4 Not met Not met: no proband phenotype or family-history documentation was available to establish a highly specific phenotype.
clinvar PMID:25741868
PP5 Not met Not met: the only ClinVar submission is a single 1-star laboratory classification, not an expert-panel classification as this criterion requires.
clinvar PMID:25741868
BA1 Not met Not met: allele frequency is zero (absent from gnomAD v2.1, v4.1, and gnomAD-Canada), far below the 5% BA1 threshold.
gnomad_v2 gnomad_v4 gnomad_canada
BS1 Not met Not met: allele frequency zero (absent from all three gnomAD cohorts) is far below the 0.3% BS1 threshold.
gnomad_v2 gnomad_v4 gnomad_canada PMID:19545378
BS2 Not met Not met: no heterozygous or homozygous observations exist in population cohorts, so no healthy-adult carrier evidence is available.
gnomad_v2 gnomad_v4 gnomad_canada
BS3 Not assessed Not assessed: no functional study demonstrating preserved protein function or splicing was available for this variant.
PMID:25741868 spliceai oncokb PMID:9643284 generic_acmg_combination_rules
BS4 Not assessed Not assessed: no family genotype data were available to evaluate whether segregation is contradicted in affected relatives.
generic_acmg_combination_rules clinvar
BP1 N/A Not applicable: no missense change is present, so this criterion for missense variants in genes with primarily truncating disease mechanisms does not apply.
generic_acmg_combination_rules
BP2 Not assessed Not assessed: no parental or family data were available to determine whether the variant lies in cis or trans with a pathogenic variant.
clinvar PMID:25741868
BP3 N/A Not applicable: no in-frame insertion or deletion in a repetitive region is present to evaluate.
pvs1_generic_framework generic_acmg_combination_rules
BP4 N/A Not applicable: the nonsense change definitively impacts the gene product, and SpliceAI's no-splice-impact prediction (0.00) does not show overall benignity.
spliceai generic_acmg_combination_rules
BP5 Not met Not met: no alternate genetic cause of disease was documented for this variant.
PMID:25741868
BP6 Not met Not met: no benign or likely-benign ClinVar assertion exists for this variant, and only expert-panel classifications qualify for this criterion.
clinvar PMID:25741868
BP7 N/A Not applicable: this criterion applies only to synonymous variants, and this is a nonsense change.
generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.